Pharmaceutical Business review

ZoomMed signs software development deal with Sharpe Medical

The EMR will provide an easy way to incorporate Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria, psychiatric practice guideline-based clinical decision support and patient education material at the point of care.

This note-writer module will comprise a comprehensive patient summary, a reports section and a clinical library.

ZoomMed president and CEO Yves Marmet said they have delivered great workflows to behavioral health providers that incorporate the DSM-4 criteria and clinical decision support at the point of care.

Sharpe Medical Consulting president Charles Motsinger said ZoomMed’s intuitive and simple interface along with a database makes them the suitable partner for this project.